Afternoon Market Update: Silver Up 2%; Alector stocks go higher

0

Towards the end of Friday’s trading, the Dow rose 0.46% to 34,792.90 while the NASDAQ rose 0.67% to 14,619.12. The S&P also rose 0.66% to 4,348.47.

The US has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,680,520 cases with around 605,030 deaths. India confirmed a total of at least 30,458,250 cases and 400,310 deaths, while Brazil reported over 18,622,300 COVID-19 cases with 520,090 deaths. In total, there have been at least 182,685,990 cases of COVID-19 worldwide, with more than 3,956,750 deaths, according to Johns Hopkins University.

Leading and trailing sectors

IT stocks rose 1.2% on Friday. The top winners in the industry are now among them Marin Software Incorporated (NASDAQ: MRIN), up 38%, and Cerence Inc. (NASDAQ: CRNC), up 16%.

Energy stocks fell 0.2% in Friday’s trading.

Top headline

The US economy created 850,000 jobs in June, the strongest job growth in ten months. The US unemployment rate rose to 5.9% in June.

Stock trading UP

Eco Wave Power Global AB (NASDAQ: WAVE) stocks shot up 79% to $ 19.43. A 13G filing by Alpha Capital showed an 8.7% stake in the company.

Shares in Alector, Inc. (NASDAQ: ALEC) received a boost, rising 53% to $ 34.37. Alector and GlaxoSmithKline have announced a global collaboration to develop and commercialize two monoclonal antibodies to increase progranulin (PGRN) levels.

TAT Technologies Ltd. Shares (NASDAQ: TATT) also gained 39% to $ 8.21 after the company announced a new MRO partnership with Honeywell.

Check out these great movers and shakers of the day

Stock trading DOWN

Iterum Therapeutics plc (NASDAQ: ITRM) shares fell 38% to $ 1.4167 after the company received a letter from the FDA regarding a review of its sulopenemetzadroxil / probenecid regulatory filing for uncomplicated urinary tract infections. The agency has identified deficiencies that currently preclude a discussion of the labeling and post-marketing requirements / obligations.

Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) declined 26% to $ 63.01 after the company voluntarily suspended the AROENaC1001 Phase 1/2 study to test ARO-ENaC for cystic fibrosis. The decision was made after receiving a preliminary update from an ongoing chronic toxicology study in rats showing unexpected signals of local pneumonia.

Alterity Therapeutics Limited (NASDAQ: ATHE) fell and fell 21% to $ 1.69. The filing by Alterity Therapeutics Australia showed a proposed offering of 322,857,900 shares. Alterity Therapeutics’ shares rose roughly 65% ​​Thursday after the company announced it had received a new US patent for key neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

raw materials

On the commodities news, oil traded 0.1% to $ 75.18 while gold rose 0.8% to $ 1,790.90.

Silver rose 2.1% on Friday to $ 26.645 while copper rose 1.3% to $ 4.2920.

Eurozone

European stocks closed today mixed. The STOXX 600 in the euro zone rose by 0.26%, the Spanish Ibex index by 0.28% and the German DAX 30 by 0.3%. Meanwhile, the London FTSE 100 fell 0.03%, the French CAC 40 fell 0.01% and the Italian FTSE MIB fell 0.01%.

The French national budget deficit rose slightly in January-May to EUR 118.8 billion compared to EUR 117.9 billion in the same period of the previous year. Spain’s unemployment fell by 166,911 to 3.61 million in June.

economy

The US economy created 850,000 jobs in June, the strongest job growth in ten months. The US unemployment rate rose to 5.9% in June.

The trade deficit increased to $ 71.2 billion in May.

US factory orders rose 1.7% in May after a revised 0.1% decrease in the previous month.

The total number of active U.S. oil rigs this week rose 4 to 376, reported Baker Hughes Inc.

View the full economic calendar here

© 2021 Benzinga.com. Benzinga does not offer investment advice. All rights reserved.

Leave A Reply

Your email address will not be published.